Previous studies have demonstrated that elevated expression of SKP2 enhances glycolysis and facilitates tumor progression by promoting the degradation of isocitrate dehydrogenase 1 (IDH1) (15, 16, 17). This evidence concerns the gene SKP2 and neoplasm.